The role of pharmaceutical marketing and other factors in prescribing decisions: The Yemeni experience

Research in Social and Administrative Pharmacy

Volumn 9, Issue 6, 2013, Pages 981-988

  Al Areefi, Mahmoud Abdullah ^a   Hassali, Mohamed Azmi ^a   Mohamed Ibrahim, Mohamed Izham b ^b  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b Qatar University ^*  (Qatar)

Author keywords

Critical incidents; Pharmaceutical marketing; Prescribing decisions; Qualitative study

Indexed keywords

ADULT; ARTICLE; CLINICAL PRACTICE; CRITICAL INCIDENTS; DECISION MAKING; DRUG INDUSTRY; FEMALE; HUMAN; MALE; MARKETING; MIDDLE AGED; PHARMACEUTICAL MARKETING; PRESCRIBING DECISIONS; PRESCRIPTION; QUALITATIVE RESEARCH; YEMEN;

CRITICAL INCIDENTS; PHARMACEUTICAL MARKETING; PRESCRIBING DECISIONS; QUALITATIVE STUDY;

ADULT; DECISION MAKING; DRUG INDUSTRY; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MARKETING; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; YEMEN;

EID: 84887606511     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2012.10.006     Document Type: Article

References (16)

1. Dukes M.N.G. Drug Utilization Studies: Methods and Uses 1993, WHO Regional Office for Europe.
2. Sterky G., Tomson G., Diwan V.K., Sachs L. Drug use and the role of patients and prescribers. J Clin Epidemiol 1991, 45(suppl 2):67-72.
3. Norris P., Herxheimer A., Lexchin J., Mansfield P. Drug Promotion. What We Know, What We Have Yet to Learn Reviews of Materials in the WHO/HAI Database on Drug Promotion 2005, WHO/HAI, Amsterdam.
4. Gönül F.F., Carter F., Petrova E., Srinivasan K. Promotion of prescription drugs and its impact on physicians' choice behavior. J Market 2001, 79-90.
5. Annual Report 2010, SBDMA, Supreme Board of Drug and Medical Appliances, Sana'a.
6. Jacoby A., Smith M., Eccles M. A qualitative study to explore influences on general practitioners' decisions to prescribe new drugs. Br J Gen Pract 2003, 53:120.
7. Prosser H., Almond S., Walley T. Influences on GPs' decision to prescribe new drugs-the importance of who says what. Fam Pract 2003, 20:61-68.
8. Ljungberg C., Lindblad Å.K., Tully M.P. Hospital doctors' views of factors influencing their prescribing. JEval Clin Pract 2007, 13:765-771.
9. Buusman A., Andersen M., Merrild C., Elverdam B. Factors influencing GPs' choice between drugs in a therapeutic drug group. A qualitative study. Scand J Prim Health Care 2007, 25:208-213.
10. Tobin L., de Almedia N.A.C., Wutzke S., et al. Influences on the prescribing of new drugs. Aust Fam Physician 2008, 37:78.
11. Flanagan J.C. The critical incident technique. Psychol Bull 1954, 51:327-358.
12. Wilson TD. Alfred Schutz, phenomenology and research methodology for information behaviour research,2002.
13. Wazana A. Physicians and the pharmaceutical industry. JAMA 2000, 283:373.
14. Campbell E.G. Doctors and drug companies-scrutinizing influential relationships. N Engl J Med 2007, 357:1796-1797.
15. Greene J.A. Pharmaceutical marketing research and the prescribing physician. Ann Intern Med May 15, 2007, 146:742-748.
16. Montaner J.S.G., O'Shaughnessy M.V., Schechter M.T. Industry-sponsored clinical research: a double-edged sword. Lancet 2001, 358:1893-1895.